TACHOSIL

This brand name is authorized in Austria, Brazil, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug TACHOSIL contains a combination of these active pharmaceutical ingredients (APIs):

1 Human fibrinogen UNII N94833051K - FIBRINOGEN HUMAN

Human fibrinogen (coagulation factor I), in the presence of thrombin, activated coagulation factor XIII (F XIIIa) and calcium ions is converted into a stable and elastic three-dimensional fibrin haemostatic clot. The administration of human fibrinogen concentrate provides an increase in plasma fibrinogen level and can temporarily correct the coagulation defect of patients with fibrinogen deficiency. Read about Human fibrinogen

2 Thrombin UNII 6K15ABL77G - HUMAN THROMBIN

Read about Thrombin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BC30	Combinations	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BC Local hemostatics
Discover more medicines within B02BC30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501104501170319
Country: EE	Ravimiamet	Identifier(s): 1207875, 1212220, 1212231, 1212242, 1687204
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 04277001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 019293, 019435, 019440
Country: FR	Base de données publique des médicaments	Identifier(s): 61695844
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 147173, 147177, 90677
Country: HK	Department of Health Drug Office	Identifier(s): 61690, 61691, 63148
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6689, 7483
Country: IT	Agenzia del Farmaco	Identifier(s): 036557015, 036557027, 036557039, 036557041, 036557054
Country: JP	医薬品医療機器総合機構	Identifier(s): 6349802X1020, 6349802X2027, 6349802X3023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030977, 1030978, 1030979, 1030980, 1076190
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100027378
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68190001, W68190002, W68190003
Country: SG	Health Sciences Authority	Identifier(s): 14441P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683324499235
Country: US	FDA, National Drug Code	Identifier(s): 0338-8701, 0338-8702
Country: ZA	Health Products Regulatory Authority	Identifier(s): 45/8.1/0937